Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IP6K1 | Q92551 | 9/20 | 0.55 |
| ▸ | IP6K3 | Q96PC2 | 4/20 | 0.55 |
| ▸ | IP6K2 | Q9UHH9 | 1/20 | 0.51 |
| ▸ | ACVR1 | Q04771 | 3/20 | 0.46 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.46 |
| ▸ | PARP1 | P09874 | 6/20 | 0.45 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.45 |
| ▸ | PIM1 | P11309 | 1/20 | 0.45 |
| ▸ | AKT1 | P31749 | 1/20 | 0.45 |
| ▸ | FLT3 | P36888 | 1/20 | 0.45 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30095507 | 1.00 | IP6K1 (0.55) | IP6K1IP6K3IP6K2ACVR1MAP3K5 | |
| SCHEMBL22473968 | 0.81 | MAP3K5 (0.46) | MAP3K5 | |
| SCHEMBL30095442 | 0.79 | MAP3K5 (0.40) | MAP3K5 | |
| SCHEMBL28899177 | 0.79 | MAP3K5 (0.40) | MAP3K5 | |
| SCHEMBL28899198 | 0.79 | MAP3K5 (0.40) | MAP3K5 | |
| SCHEMBL30095416 | 0.79 | MAP3K5 (0.40) | MAP3K5 | |
| SCHEMBL30095482 | 0.76 | MAP3K5 (0.43) | MAP3K5 | |
| SCHEMBL28899147 | 0.76 | MAP3K5 (0.43) | MAP3K5 | |
| SCHEMBL28899176 | 0.75 | MAP3K5 (0.47) | MAP3K5PARP1 | |
| SCHEMBL10222569 | 0.73 | MAP3K5 (0.47) | MAP3K5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109456308-B | Heterocyclic compounds as ASK inhibitors and their use | 南京圣和药业股份有限公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-109456308-A | Heterocyclic compound and its application as ASK inhibitor | 南京圣和药业股份有限公司 | 2019-03-12 | — | — | CN | disclosed |